Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Heart Transplant. 1987 Mar-Apr;6(2):120-2.

Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.

Abstract

Primary cytomegalovirus infection in the patient who is receiving immunosuppression therapy is associated with a high morbidity and mortality. We report a patient who developed primary cytomegalovirus infection 37 days after heart transplantation with a rapidly deteriorating course. Treatment with the new antiviral drug trisodium phosphonoformate (Foscarnet-Astra) was initiated as a lifesaving measure with rapid, dramatic improvement in the patient's condition and subsequent recovery.

PMID:
3040944
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk